Stride (LRN)
(Delayed Data from NYSE)
$67.71 USD
-0.19 (-0.28%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $67.78 +0.07 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$67.71 USD
-0.19 (-0.28%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $67.78 +0.07 (0.10%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum C VGM
Zacks News
Stride (LRN) Unveils New Content Options With Wonder Media
by Zacks Equity Research
Stride (LRN) to fulfill its commitment to deliver an engaging, standards-aligned curriculum for K-12 students.
Is Stride (LRN) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how K12 (LRN) and Panasonic Corp. (PCRFY) have performed compared to their sector so far this year.
Stride (LRN) Q4 Earnings & Revenues Top Estimates, Shares Up
by Zacks Equity Research
Stride's (LRN) fiscal fourth-quarter 2023 results reflect growth in Career Learning enrollment demand as well as revenue per enrollment.
Stride's (LRN) MedCerts Partners With GW University Hospital
by Zacks Equity Research
Stride's (LRN) subsidiary unit MedCerts collaborates with The GW University Hospital, boosting career opportunities in healthcare.
Best Growth Stocks to Buy for June 26th
by Zacks Equity Research
ENS, LRN and VRT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26, 2023.
Best Growth Stocks to Buy for June 23rd
by Zacks Equity Research
CCU, LRN and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 23, 2023.
Best Growth Stocks to Buy for June 21st
by Zacks Equity Research
LRN, PERI and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 21, 2023.
Best Growth Stocks to Buy for June 20th
by Zacks Equity Research
PHM, LRN and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 20, 2023.
Draftkings (DKNG) Improves Bid for PointsBet's US Business
by Zacks Equity Research
DraftKings (DKNG) submits an improved offer to acquire PointsBet's US operations for $195 million.
Stride's (LRN) MedCerts Unveils Healthcare Courses via Coursera
by Zacks Equity Research
Stride's (LRN) MedCerts joins Coursera for its healthcare courses and expands its reach.
Best Growth Stocks to Buy for June 15th
by Zacks Equity Research
LRN, VRT and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2023.
Stride's (LRN) Unit MedCerts Collaborates With Mason Center
by Zacks Equity Research
Stride's (LRN) MedCerts enters into a healthcare education partnership with Mason Center to broaden opportunities in Tennessee.
Zacks.com featured highlights include Stride, Linde, Sterling Infrastructure and Atmos Energy
by Zacks Equity Research
Stride, Linde, Sterling Infrastructure and Atmos Energy are part of the Zacks Screen of the Week article.
Scoop Up These 4 Promising Interest Coverage Ratio Stocks
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Stride (LRN), Linde (LIN), Sterling Infrastructure (STRL) and Atmos (ATO) are sound enough to meet financial obligations.
Best Growth Stocks to Buy for May 31st
by Zacks Equity Research
VRT, LRN and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 31, 2023.
Best Growth Stocks to Buy for May 30th
by Zacks Equity Research
EZPW, GPK and LRN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 30, 2023.
Best Growth Stocks to Buy for May 25th
by Zacks Equity Research
VRT, EZPW and LRN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 25, 2023.
The Zacks Analyst Blog Highlights Assurant, EZCORP, Lifetime Brands, Stride and On Holding
by Zacks Equity Research
Assurant, EZCORP, Lifetime Brands, Stride and On Holding are included in this Analyst Blog.
Zacks.com featured highlights Stride, BellRing, Linde and AMETEK
by Zacks Equity Research
Stride, BellRing, Linde and AMETEK have been highlighted in this Screen of The Week article.
Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio
by Sumit Singh
A company capable of generating earnings well above its interest expense can withstand financial hardship. Stride (LRN), BellRing Brands (BRBR), Linde (LIN) and AMETEK (AME) are sound enough to meet financial obligations.
5 Undervalued Stocks with Long-Term Potential
by Sejuti Banerjea
As investors, we are forever searching for stocks that are below their intrinsic value.
Best Growth Stocks to Buy for May 23rd
by Zacks Equity Research
LRN, PERI and GPK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 23, 2023.
Best Growth Stocks to Buy for May 22nd
by Zacks Equity Research
OLLI, PHM and LRN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 22, 2023.
Take-Two (TTWO) Reports Loss in Q4, Revenues Increase Y/Y
by Zacks Equity Research
Take-Two's (TTWO) fourth-quarter fiscal 2023 results benefit from robust portfolio strength, driving Game and advertising revenues.
K12 (LRN) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
K12 (LRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.